[1]
Sio, T. et al. 2020. Long-Term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients With Centrally Located Thoracic Tumors: SABR for Central Thoracic Tumors. Radiology and Oncology. 54, 4 (Nov. 2020), 480–487.